<DOC>
	<DOCNO>NCT02848521</DOCNO>
	<brief_summary>This prospective , non-interventional study ( NIS ) measure health-related quality life ( HRQoL ) , treatment satisfaction , patient-reported outcome ( PROs ) ADPKD patient Europe .</brief_summary>
	<brief_title>A Study Measuring Quality Life , Treatment Preference Satisfaction ADPKD Patients Europe</brief_title>
	<detailed_description />
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Polycystic Kidney Diseases</mesh_term>
	<mesh_term>Polycystic Kidney , Autosomal Dominant</mesh_term>
	<criteria>Male female age â‰¥ 18 year . Patient diagnosis ADPKD CKD Stages 13 , deem treat physician likely rapidly progress disease . Patient life expectancy great 18 month time enrolment . Patient able willing give inform consent , require accord local regulation . Patient fluent local language . Patient currently participate , last 12 month participate interventional clinical trial . Presence condition/circumstance opinion investigator could significantly limit complete follow patient . Inability patient complete PROs remotely .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2017</verification_date>
	<keyword>ADPKD</keyword>
	<keyword>CKD</keyword>
	<keyword>Rapid progressor</keyword>
	<keyword>quality life</keyword>
	<keyword>DCE</keyword>
</DOC>